Purification and characterization of a novel subtype A3 botulinum neurotoxin

Applied and Environmental Microbiology

Volumn 78, Issue 9, 2012, Pages 3108-3113

  Tepp, William H ^a   Lin, Guangyun ^a   Johnson, Eric A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTERRORISM AGENT; BOTULINUM; BOTULINUM NEUROTOXINS; CLOSTRIDIUM BOTULINUM; LETHAL DOSE; LONG DURATION; LOW LEVEL; MOUSE BIOASSAY; PHARMACOLOGICAL PROPERTIES; POLYCLONAL; PURIFICATION METHOD; PURIFICATION PROCEDURES; TOXIN PRODUCTION;

ANTIBODIES; BIOASSAY; BIOTERRORISM; CLOSTRIDIUM; INNOVATION; MAMMALS; PATIENT TREATMENT; TOXICITY;

PURIFICATION;

ANTITOXIN; BACTERIUM ANTIBODY; BOTULINUM TOXIN A;

ANTIBODY; BACTERIUM; BIOASSAY; BIOCHEMICAL COMPOSITION; BIOTERRORISM; DRUG; NEUTRALIZATION; PURIFICATION; RODENT; SYMPTOM; TOXICITY; TOXIN;

ANIMAL; ARTICLE; BIOASSAY; BOTULISM; CHEMISTRY; CLOSTRIDIUM BOTULINUM; CULTURE MEDIUM; DISEASE MODEL; IMMUNOLOGY; ISOLATION AND PURIFICATION; LD 50; MORTALITY; MOUSE; PATHOLOGY; SERODIAGNOSIS;

ANIMALS; ANTIBODIES, BACTERIAL; ANTITOXINS; BIOLOGICAL ASSAY; BOTULINUM TOXINS, TYPE A; BOTULISM; CLOSTRIDIUM BOTULINUM; CULTURE MEDIA; DISEASE MODELS, ANIMAL; LETHAL DOSE 50; MICE; NEUTRALIZATION TESTS;

ANIMALIA; CLOSTRIDIUM BOTULINUM; MUS;

EID: 84861165932     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.07967-11     Document Type: Article

References (31)

1. Arnon SS, et al. 2001. Botulinum toxin as a biological weapon: medical and public health management. JAMA 285:1059-1070.
2. Ascher B, et al. 2010. International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit)-part I: upper facial wrinkles. J. Eur. Acad. Dermatol. Venereol. 24:1278-1284.
3. Ascher B, et al. 2010. International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit)-part II: wrinkles on the middle and lower face, neck and chest. J. Eur. Acad. Dermatol. Venereol. 24:1285-1295.
4. Bandyopadhyay S, Clark AW, DasGupta BR, Sathyamoorthy V. 1987. Role of the heavy and light chains of botulinum neurotoxin in neuromuscular paralysis. J. Biol. Chem. 262:2660-2663.
5. Bellevue S. 2006. Master's thesis. University of Wisconsin, Madison, WI.
6. Binz T, et al. 1994. Proteolysis of SNAP-25 by types E and A botulinal neurotoxins. J. Biol. Chem. 269:1617-1620.
7. Carter AT, et al. 2009. Independent evolution of neurotoxin and flagellar genetic loci in proteolytic Clostridium botulinum. BMC Genomics 10:115.
8. DasGupta BR, Sathyamoorthy V. 1984. Purification and amino acid composition of type A botulinum neurotoxin. Toxicon 22:415-424.
9. Dover N, Barash JR, Arnon SS. 2009. Novel Clostridium botulinum toxin gene arrangement with subtype A5 and partial subtype B3 botulinum neurotoxin genes. J. Clin. Microbiol. 47:2349-2350.
10. Foran P, Lawrence GW, Shone CC, Foster KA, Dolly JO. 1996. Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release. Biochemistry 35:2630-2636.
11. Hatheway CL. 1988. Botulism, p 111-133. In Balows A (ed), Laboratory diagnosis of infectious diseases: principles and practice. Springer-Verlag, New York, NY.
12. Horowitz BZ. 2011. The ripe olive scare and Hotel Loch Maree tragedy: botulism under glass in the 1920's. Clin. Toxicol. 49:345-347.
13. Jacobson MJ, Lin G, Raphael B, Andreadis J, Johnson EA. 2008. Analysis of neurotoxin cluster genes in Clostridium botulinum strains producing botulinum neurotoxin serotype A subtypes. Appl. Environ. Microbiol. 74:2778-2786.
14. Jacobson MJ, et al. 2011. Purification, modeling, and analysis of neurotoxin BoNT/A5 from Clostridium botulinum strain A661222. Appl. Environ. Microbiol. 77:4217-4222.
15. Jacobson MJ, Lin G, Whittam TS, Johnson EA. 2008. Phylogenetic analysis of Clostridium botulinum type A by multi-locus sequence typing. Microbiology 154:2408-2415.
16. Johnson EA. 1999. Clostridial toxins as therapeutic agents: benefits of nature's most toxic proteins. Annu. Rev. Microbiol. 53:551-575.
17. Lacy DB, Stevens RC. 1999. Sequence homology and structural analysis of the clostridial neurotoxins. J. Mol. Biol. 291:1091-1104.
18. Lacy DB, Tepp W, Cohen AC, DasGupta BR, Stevens RC. 1998. Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat. Struct. Biol. 5:898-902.
19. Lin G, Tepp WH, Pier CL, Jacobson MJ, Johnson EA. 2010. Expression of the Clostridium botulinum A2 neurotoxin gene cluster proteins and characterization of the A2 complex. Appl. Environ. Microbiol. 76:40 - 47.
20. Malizio CJ, Goodnough MC, Johnson EA. 2000. Purification of Clostridium botulinum type A neurotoxin. Methods Mol. Biol. 145:27-39.
21. Marshall KM, Bradshaw M, Pellett S, Johnson EA. 2007. Plasmid encoded neurotoxin genes in Clostridium botulinum serotype A subtypes. Biochem. Biophys. Res. Commun. 361:49-54.
22. Mazuet C, Dano J, Popoff MR, Creminon C, Volland H. 2010. Characterization of botulinum neurotoxin type A neutralizing monoclonal antibodies and influence of their half-lives on therapeutic activity. PLoS One 5:e12416.
23. Mueller JH, Schoenbach EB, Jezukawicz JJ, Miller PA. 1943. Production of tetanus toxin on peptone-free media. J. Clin. Invest. 22:315-318.
24. Reed LJ, Muench H. 1938. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27:493-497.
25. Schiavo G, Rossetto O, Santucci A, DasGupta BR, Montecucco C. 1992. Botulinum neurotoxins are zinc proteins. J. Biol. Chem. 267:23479 - 23483.
26. Schiavo G, Shone CC, Bennett MK, Scheller RH, Montecucco C. 1995. Botulinum neurotoxin type C cleaves a single Lys-Ala bond within the carboxyl-terminal region of syntaxins. J. Biol. Chem. 270: 10566-10570.
27. Singh JA. 2010. Botulinum toxin therapy for osteoarticular pain: an evidence-based review. Ther. Adv. Musculoskelet. Dis. 2:105-118.
28. Smith LDS, Sugiyama H. 1988. Botulism. The organism, its toxins, the disease. Charles C Thomas, Springfield, IL.
29. Smith GR, Moryson CJ. 1977. A comparison of the distribution of Clostridium botulinum in soil and in lake mud. J. Hyg. (Lond.) 78: 39 - 41.
30. Smith TJ, et al. 2007. Analysis of the neurotoxin complex genes in Clostridium botulinum A1-A4 and B1 strains: BoNT/A3, /Ba4 and /B1 clusters are located within plasmids. PLoS One 2:e1271.
31. Webb RP, Smith TJ, Wright P, Brown J, Smith LA. 2009. Production of catalytically inactive BoNT/A1 holoprotein and comparison with BoNT/A1 subunit vaccines against toxin subtypes A1, A2, and A3. Vaccine 27:4490-4497.